Search

everythinglearnresearchcommunity

for

Search:↓

A model using hormone levels, cycle length, and BMI can help identify PCOS in Chinese women but isn't for screening teens.

Lifestyle changes and insulin-sensitizing drugs are effective for managing PCOS.

Myo-inositol-based treatments greatly improve pregnancy chances for women with PCOS.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Magnesium supplements improved quality of life for women with polycystic ovary syndrome, but didn't help with acne, hair loss, or abnormal bleeding.

AMH is a promising biomarker for diagnosing PCOS.

Pro-, pre-, and synbiotics may help with PCOS, but more research is needed.

Combining spironolactone with metformin reduces insulin resistance in PCOS better than either drug alone.

Overweight women with PCOS are more likely to have excess male hormones.

Androgen measurement helps diagnose PCOS, but accuracy varies, needing standard methods.

Metformin effectively reduces hormone levels in women with PCOS.

Quercetin may help improve symptoms of polycystic ovary syndrome.

Interest in Acanthosis nigricans research is growing, highlighting key focus areas and influential work.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Finasteride-loaded proniosomes effectively promote hair growth in mice.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

The food supplement improved hair growth and strength in people with a certain type of hair loss and had no major side effects.

Nanomaterials could improve PCOS treatment by delivering drugs more effectively with fewer side effects.

Evaluate and manage androgen excess in women with a systematic approach, considering both physical and psychological impacts.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Women with both type 2 diabetes and PCOS have worse metabolic issues but milder reproductive symptoms after sleeve gastrectomy.

Myricetin shows promise as an anticancer agent by reducing inflammation and enhancing drug effectiveness.

In STSD patients, the body compensates for low androgen levels by increasing another enzyme's activity.

Testosterone treatment may change estrogen receptor methylation in AFAB individuals.

Insurance coverage for scalp cooling will make it more accessible to all chemotherapy patients.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

Obesity leads to physical, metabolic, reproductive issues, higher healthcare costs, and mental health problems.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.

Resveratrol shows health benefits but faces challenges in effectiveness and regulation.